Co-Directors:Tom Ellenberger, DVM, PhD and Evan Kharasch, MD, PhD
The Pharmacology Core is dedicated to providing the broad base of sophisticated analytical equipment and expertise in pharmacology required for preclinical and clinical investigations of anti-cancer drugs and related therapies. The core provides:
Analytical support for basic and clinical scientists at the Siteman Cancer Center that would not otherwise be available
Expertise for design of more informative and innovative therapeutic studies.
Pharmacology information to provide education and training to students, postdoctoral fellows and investigators in the performance of pre-clinical/clinical pharmacology studies.
LOCATION: Clinical Sciences Research Building, Room 1021
TO ACCESS: Call Tom Ellenberger at 314-747-8893; or e-mail firstname.lastname@example.org.
As of April 7, 2008, the NIH requires investigators with a publication using Siteman (or other NIH-funded) shared resources to submit (or have submitted for them) their final, peer reviewed manuscripts to PubMed Central(PMC) upon acceptance of publication, to be made publicly available within 12 months of publication. Many journals automatically submit these for authors, but Washington University also has assistance available through the Becker Medical Library. Please see http://publicaccess.nih.gov/FAQ.htm#b7 or http://becker.wustl.edu/classes-consulting/specialized-expertise/nih-public-access-policy for more information.
PUBLICATION ACKNOWLEDGEMENT: If research supported by the Pharmacology Core results in publication, please acknowledge this support by including the following in your publication(s):
We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Mo., for the use of the Pharmacology Core, which provided __________ service. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA91842.